In this paper, we have investigated the combined effects of RT with the beta-emitting radionuclide lutetium-177 and CP immunotherapy using anti-PD-L1 and anti-CTLA-4 in an E0771 murine TNBC tumor model. The gene discussed is CTLA4; the disease is neoplasm.